# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
HC Wainwright & Co. analyst Yi Chen reiterates OPKO Health (NASDAQ:OPK) with a Buy and maintains $3 price target.
OPKO Health (NASDAQ:OPK) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.10) ...
HC Wainwright & Co. reiterates OPKO Health (NASDAQ:OPK) with a Buy and maintains $3 price target.